Random

MDMA

·July 10, 2017·5 min read

On-Site Ecstasy Pill Testing Service May Reduce User Risks at Concerts and Raves

Researchers from Johns Hopkins University have found that free ecstasy pill testing at raves and concerts could have a positive impact in preventing some people from using adulterated drugs. The study, researchers say, adds to critical evidence that on site pill testing is a valuable tool for public health and safety.

Featured Psychology

·September 15, 2015·3 min read

Documenting Self Reported Use of New Synthetic Drugs by Teens and Young Adults

A new study reports on the self reported use of new synthetic drugs among teens and young people.

Featured Neuroscience Psychology

·December 11, 2019·7 min read

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Researchers have distinguished two different molecular pathways responsible for addiction and the prosocial feelings generated by MDMA. The findings could lead to novel treatments for psychiatric disorders marked by withdrawal and social awkwardness.

This shows a brain overlayed on a person's head with a swirly, psychedelic background

Featured Neuroscience Psychology

·April 4, 2019·5 min read

Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD

MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.

Featured Neuroscience

·July 17, 2013·3 min read

Low Doses of Psychedelic Drug Erases Conditioned Fear in Mice

Researchers discover a low dose of psilocybin erased conditioned fear responses in mice. They suggest the agent could be a potential treatment for PTSD and related conditions.

Featured Neuroscience Psychology

·September 1, 2019·5 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.

Featured Neuroscience Open Neuroscience Articles

·October 9, 2017·3 min read

Human Minibrains Reveal Effects of Psychedelic Substance

A new study reveals psychedelic substances may have a neuroprotective role when it comes to inflammation. Researchers also report psychedelics can alter signaling pathways associated with neuroplasticity.

Featured Neuroscience Psychology

·August 19, 2018·5 min read

The Real Promise of LSD, Mushrooms and MDMA for Medical Science

Researchers explore why using hallucinogens to treat an array of mental health disorders is becoming more popular.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 11, 2020·3 min read

Cannabis increases susceptibility to false memory

In comparison to a placebo group, test subjects exposed to marijuana were more likely to form false memories based on incorrect information.

Featured Psychology

·August 12, 2018·3 min read

Exploring the Potential Benefits of Hallucinogens for Mental Health

Researchers explore the potential benefits of using hallucinogens for the treatment of PTSD, anxiety, depression and other mental health disorders.

Featured Neuroscience Psychology

·January 9, 2023·12 min read

The Rebirth of Psychedelic Medicine

Often considered dangerous, mind-altering drugs, researchers are turning to the study of psychedelic therapies as a potential to treat an array of psychiatric conditions including depression and PTSD.